Oleunor N5e (Glycine, Magnesium Chloride Hexahydrate, Potassium Chloride, Calcium Chloride Dihydrate, L-Lysine Ac)

Oleunor N5e is used in clinical situations that require rapid correction of electrolyte disturbances and metabolic support.

• Hypokalemia: helps restore normal potassium levels in patients with low serum potassium.
• Hypomagnesemia: provides magnesium to correct deficient states.
• Calcium deficiency: supplies calcium for patients with low calcium concentrations.
• Metabolic support during surgery: assists in maintaining electrolyte homeostasis during operative procedures.
• Post‑operative recovery: aids in re‑establishing electrolyte balance after major surgery.

• Oleunor N5e delivers a balanced mixture of essential electrolytes and amino acids directly into the bloodstream. The magnesium, potassium, and calcium ions participate in enzymatic reactions, nerve impulse transmission, and muscle contraction, while glycine acts as a neurotransmitter and co‑factor for detoxification pathways. L‑lysine acetate contributes to protein synthesis and tissue repair, together supporting overall cellular metabolism.

Potential adverse reactions may occur with any intravenous electrolyte preparation.

Common Side Effects

• Mild infusion site irritation
• Transient flushing or warmth
• Slight nausea
• Headache
• Temporary increase in serum calcium or potassium levels
• Mild dizziness

Serious or Rare Side Effects

• Severe hyperkalemia or hypermagnesemia
• Cardiac arrhythmias
• Anaphylactic reaction
• Significant hypotension
• Acute kidney injury
• Metabolic acidosis

Oleunor N5e should be administered carefully, with attention to patient‑specific factors and monitoring requirements.

• Renal impairment: adjust infusion rate and monitor electrolytes closely.
• Cardiac disease: observe for arrhythmias during administration.
• Fluid overload risk: assess volume status.
• Concomitant electrolyte therapy: avoid duplicate dosing.
• Pregnancy :    
• Store at 2-8°C: keep refrigerated  

-  

• Oleunor  
• ---
• ---  
•    
•       "  "  " "  " "